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availability 
 
Supervising Professors:  Dr. Kevin Dalby, Dr. Goheun Kim  
 
 
For my thesis, I will be looking at the history of cancer and its treatments, and the 
influence of the public’s perception about cancer on modern day treatments based on regional 
differences. The history of cancer involves analyzing when and where cancer was first 
“discovered” and observed, and how treatments of the illness began. Based on this, different 
regions of the world have developed different methods for analyzing and treating cancer, 
potentially based on cultural, social, and technological differences and perspectives. After 
analyzing and compiling a history of cancer and its treatment, I will analyze how different 
regions perceive cancer today based on this history and investigate whether these perceptions 
among different groups were based on a region’s infrastructure, or an individual’s 
socioeconomic status, education, and potentially gender in that region.  
Next, I analyzed and interpreted how cancer treatments vary in different regions, and 
whether the difference in treatments was based on the different perceptions among different 
groups. I hope to also answer the question about why treatments differ based on analysis of these 
perceptions, affordability, availability and environmental differences. I also wanted to determine 
if perception of cancer and its treatment among individuals affects compliance to these 
treatments.  
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Introduction 
Cancer is a treacherous disease that has been around since the beginning of humankind. 
Although humans have been experiencing its deadly grasp for thousands of years, cancer has still 
not been officially cured; there is no definitive way to prevent its occurrence. According to the 
World Health Organization, 18.1 million cases of cancer arose in the world just in 2018, and in 
the same year, 9.6 million individuals died from the illness (“Latest Global Cancer Data”). One 
out of every five men and one out of every six women, on average, develop cancer in their 
lifetime in the world. Each year, cancer is a growing burden that scientists and researchers 
around the world are fighting to control.  
However, scientists have been able to develop treatments and therapies that slow its 
growth or mostly make it disappear in certain cases. Cancer is a disease that is characterized by 
somatic cells that divide abnormally and uncontrollably to form tumors. Tumors are large masses 
of rapidly dividing cells. Tumor cells are also unique in the fact that they usually ignore signals 
that normally tell cells to undergo apoptosis (or programmed cell death) or senescence (a 
permanent arrest in cell cycle). Tumor cells can influence healthy cells that form blood vessels 
and tissues that surround them. The difference between a tumor that is cancerous, called a 
malignant tumor, and a tumor that is not cancerous, called a benign tumor, is how the tumor 
moves and affects the rest of the body. Malignant tumors, if not treated or removed early enough, 
can invade the tissue surrounding it or travel to other parts of the body (a process formally called 
metastasis) and begin to form malignant tumors there as well. Benign tumors do not invade and 
travel to different parts of the body and thus can be more easily removed. Although many 
cancers are caused by malignant tumors, not all are; some cancers, like those that start from 
blood-forming tissues (leukemias), do not form tumors. There are also many different forms of 
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cancer depending on the type of tissue the tumor grows in or travels from. Some of the most 
common cancers across the world are lung cancer, breast cancer, prostate cancer, and ovarian 
cancer.  The treatments used for each type of cancer vary depending on the individual and the 
unique properties of the individual cancer cells. The three most common forms of treatment are 
surgery, radiation therapy, and chemotherapy, which will be discussed later. 
A reasonable question to ask next is what triggers the rapid growth of cancerous cells. 
Cancer is a genetic illness; its occurrence stems from mutations that manifest in specific genes 
that regulate cell division or cell death, either directly or indirectly.  A mutation occurs in DNA 
(deoxyribose nucleic acid), the hereditary molecule of life contained in the nucleus of nearly 
every cell (except red blood cells, which have no nucleus). The mutation causes damage or 
mismatch in the DNA structure - the base pairs and the backbone. These mutations can either 
result naturally or can be induced due to environmental factors that are either physical (i.e. X-
rays) or chemical (i.e. alkylating agents) in nature. Scientists have found more than 100 cancer 
genes in which mutations can fuel the progression of cells to tumorigenesis (Hartwell).. It is 
thought that most cancers require the accumulation of multiple cancer gene mutations. It is 
essential to keep in mind that the rate of mutations is low; there is approximately one mutation 
per hundred million base pairs per gamete (Hartwell). However, environmental factors can speed 
this background rate of mutation up in individuals.  
Moreover, age is a contributing factor because there is a higher chance for mutations to 
accumulate in older people than in younger people. This background information is vital to 
understanding what cancer is, how it was discovered, how people think about it, and how it has 
been treated over the years, up until the present day. In this thesis, I will first be discussing the 
history of cancer to show how our understanding of cancer has grown tremendously over 
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centuries, and how treatments arose to mitigate the mysterious illness. This understanding of 
history will then help me to analyze the regional differences in how individuals perceive cancer 
affect the procedures that are utilized in those countries, and to compare and contrast different 
countries around the world.  
History 
The history of cancer is essential to understanding the disease itself because without 
documenting its origins and development, researchers would not have been able to learn about 
the condition and use this knowledge to fight it. Although the incidence of cancer increased 
recently due to human activities, such as smoking, cancer still attacked individuals for a long 
time before this. The first record available concerning cancer is from thousands of years ago. In 
2014, a skeleton, found by Michaela Binder, a student at Durham University, was the earliest 
confirmed case of cancer. The skeleton was found at the Amara West site located in northern 
Sudan and was dated back to approximately 1,200 B.C., nearly three thousand years ago 
(Ghosh). When the skeleton was discovered, it was observed that the bones were composed of 
many small holes. This prognosis was indicative of a type of bone cancer. The earliest case of 
breast cancer was found by a team led by Professor Miguel Cecilio Botella López in 2017. The 
woman identified with breast cancer was believed to be a part of the ruling class in Egypt 
because her body was found mummified (“CT Scans of Egyptian Mummies”). The body was 
dated to be from around 2000 B.C. and was explicitly found in the Qubbet el-Haway in Aswan, 
Egypt. Computerized tomography (CT) scans were performed on the body to confirm that the 
woman died from breast cancer (“CT Scans of Egyptian Mummies”). Over the years, researchers 
have found many more skeletons and remains that provide evidence for humans having cancer 
for thousands of years, and most documented cases are in Egypt. I think that this is because 
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much of human civilization started there, where one of the largest and oldest civilizations is 
located (Mesopotamia), so a higher concentration of humans in Egypt should be expected. Also, 
at the time that these skeletons were dated to, most modern Homo sapiens were still concentrated 
in Africa and the Middle East, and had not spread across to Europe, Asia, and the Americas. 
Although many of the skeletons were found in Egypt, there was no correlation to a specific type 
of cancer in these bodies, so causation is difficult to place as to why Egyptians got cancer.  
Although these bones were found relatively recently, before these discoveries, the earliest 
record of any form of cancer in humans was found written in an ancient Egyptian manuscript 
known as the Edwin Smith Papyrus. Written around the sixteenth century B.C. (but most likely 
derived from the original text written in 3000 B.C.), the Papyrus is the oldest record available 
documenting that humans had the cancer we know today, although the word cancer was never 
mentioned (Mukherjee). It would be thousands of years until the term cancer was even coined. In 
the Edwin Smith Papyrus, there are 48 documented cases of wounds and injuries to the spinal 
cord and skull, each of which has symptoms, diagnoses, and treatments alongside them. Among 
these health issues documented, signs that closely reflected the symptoms of modern cancer 
patients (such as multiple tumors throughout the body) were found in the Papyrus as well 
(Mukherjee).  It was most likely written to act as a medical textbook discussing surgery.  
Cancer was observed in mummy bones and other fossilized bones, many of them from 
Egypt, but for thousands of years, there was no name for this terrorizing illness. It was not until 
the time of Hippocrates, who lived from 460 B.C. to 370 B.C., that a name was given to the 
disease (Mukherjee). Hippocrates was a Greek physician, known as the father of medicine, who 
coined the beginning of the word cancer. He used the terms “carcino” and “carcinoma” to 
describe tumors, which were indicative of cancer. In Greek, both carcino and carcinoma refer to 
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crab; it is believed that Hippocrates assigned the illness this name because the branching of the 
tumor from a central mass looks similar to the shape of a crab.  A few hundred years later, a 
Roman physician named Celsus changed the Greek term to the Latin word for crab, which is 
cancer (Mukherjee).  
Historical Treatment Methods 
 Different methods of cancer treatment were utilized in different parts of the world even 
though the cause of cancer was not fully understood even after being around for thousands of 
years. Different regions of the world discovered and practiced various methods of cancer 
treatment because it is likely that the ideas for how to treat cancer were different and not shared 
between individuals and doctors from region to region. Ancient Egyptians made a note, in the 
Papyrus and on other documents, that surgery could be used to remove breast tumors (early 
forms of mastectomy), but they also realized that this was not a reliable method for eradicating 
cancer (“Advancement of Cancer Survivorship”). They knew that the illness had a possibility of 
recurring. In around 1600 B.C., the Egyptians also began to use cauterization to try and remove 
the cancerous tumors they encountered. For approximately 600 years starting about 1100 B.C, 
Chinese physicians treated lumps and ulcerations, as written in The Rites of the Zhou Dynasty. 
Around 250 B.C., the Nei Ching, also known as the Yellow Emperor’s Classic of Internal 
Medicine, was written; it described breast cancer in depth, including its diagnoses, symptoms, 
and treatments. It also included a full description of tumors and different therapies used to treat 
them, including diet, acupuncture, and spiritual medicine. In India around 500 B.C., the epic tale 
known as the Ramayana mentioned using arsenic paste in an attempt to stop tumor growth. In 
Europe, Hippocrates believed that the body was made of only four bodily fluids, or humors: 
black bile, yellow bile, blood, and phlegm. This idea was called the humor theory, and it dictated 
 8 
how cancer was treated for hundreds of years, especially in Europe (“Advancement of Cancer 
Survivorship”). Because it was against many European religions to cut open the body, diagnoses 
were made based on visible symptoms and lesions. Based on the humor theory, most physicians 
agreed with Hippocrates’ theory and believed that cancer was due to an excess of black bile in 
the body (Landau). However, in the eighteenth century, this idea quickly began to shift based on 
discoveries.  
 This shift first began to blossom in the fifteenth and sixteenth century, due to the 
Renaissance movement, which promoted the idea of humanism and stimulated individuals to 
understand the human body and physiology in depth. In the fifteenth century, one of the 
influential individuals that contributed to this movement was Leonardo da Vinci. He dissected 
several bodies to see and understand the human body; his findings were documented in the 
famous Renaissance Man drawing (“Advancement of Cancer Survivorship”). From this and 
other dissections performed by various physicians across the world, it was discovered that cancer 
was not caused by a buildup of black bile, as this black bile was not found in the bodies with 
cancer. Although the humor theory was debunked, still not much was known about cancer. In the 
seventeenth century, a French physician named Claude Deshais Gendron believed that surgery 
was the only way to cure cancer and that all branches and arms of the tumor had to be removed 
(Hajdu).  He did not believe that drugs could improve cancer. He also understood the possibility 
of metastasis (although the word for this had not yet been created), but argued that if cancer had 
reached this point, there was no use in any treatment, even surgery. Starting around this time, the 
importance of early detection for cancer became prominent because many surgeons realized that 
early diagnosis could allow surgeons to completely rid individuals of cancer (“Advancement of 
Cancer Survivorship”). However, at this point, surgery was still the primary treatment available 
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for all types of cancer. For the next two centuries, the development of critical scientific tools, 
such as the microscope by Anton van Leeuwenhoek, allowed scientists to study cells in high 
definition. This invention made a significant impact on the future of cancer and its 
understanding. 
 After more research was conducted and different scientist began observing cancer, 
questions were raised as to why cancer begins and what stimulates its growth. Until this point in 
the eighteenth century, no one knew the cause of cancer. People were only able to observe its 
effects on the body. One of the first insights into the cause of cancer was developed in the 
eighteenth century by an Italian physician named Bernadino Ramazzini (Mukherjee). Considered 
the father of occupational medicine, Ramazzini first observed that there was a low rate of 
cervical cancer in nuns, but a rather high rate of breast cancer among the same group. Although 
he did not come up with any significant conclusions other than the speculation that the high rate 
of breast cancer was due to their celibate lifestyle, it was one of the first instances where the 
cause of cancer was questioned. His findings eventually led to the idea that lifestyle and 
hormones could affect the incidence of cancer in individuals (Mukherjee). Another physician 
named John Hill from London made a similar connection between lifestyle and cancer in 1761 
(Hajdu). He observed that indulgence in snuff, a form of tobacco that is crushed and inhaled, was 
possibly linked to cancer because he encountered six cases in which swellings around the nostrils 
(i.e. tumors) developed in individuals who frequently snorted snuff. Hill was the first to note that 
carcinogens could contribute to cancer development and urged people to recognize the harms of 
tobacco in his report, Cautions Against the Immoderate Use of Snuff (Hajdu). Only fourteen 
years after Hill made his discovery, another London physician named Percival Pott suggested a 
cause of cancer that originated from the idea Ramazzini had: occupation affected the likelihood 
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of getting cancer (Mukherjee). He observed that several individuals who worked as chimney 
sweeps had developed scrotal cancer. Pott believed that the cancer was caused by chimney soot 
that would collect under the scrotum (Mukherjee). This was another discovery that affirmed that 
the environment, in this case, chemicals known as carcinogens, could cause cancer directly. At 
this point, the desire to discover the cause of cancer had begun, amid a time where 
industrialization and increased pollution was contributing to increased rates of cancer in the 
population of Europe. In 1740, the first cancer hospital to date was established in France; at this 
point, the desire to find and treat cancer had become stronger than ever (“Advancement of 
Cancer Survivorship”). 
Surgery as treatment 
 Although surgery had been predominantly used to treat cancer until the 19th century, 
physicians were interested in finding different means of curing cancer. Throughout history and 
across the world, different chemicals and herbs were used to curb cancerous growth, but no non-
surgical treatment had been agreed upon as an effective treatment for cancer. However, even 
today, despite the incredible strides made in surgical technology, we know that surgery is still 
not the perfect solution. For example, in 2011, the survival rate using only surgical methods for 
patients in the United States with stage IV colon cancer was only about 20% (“Cancer Treatment 
and Survivorship Facts & Figures”). For female breast cancer patients in the United States in 
2014, breast-conserving surgery only had a two percent success rate in patients with late stage 
breast cancer (Stage III and/or IV) while mastectomies only had a seven percent success rate in 
patients with late stage breast cancer. The success rate of surgery for cancer treatment increased 
in these patients when the procedure was used in combination with other treatments, such as 
radiation therapy or chemotherapy. Similar results were found in patients with non-small cell 
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lung cancer in 2011. In these patients who had stage III or IV cancer, surgery alone was 
successful only two percent of the time. However, for patients with early stage non-small cell 
lung cancer, surgery had a 52 percent success rate (“Cancer Treatment and Survivorship Facts & 
Figures”). Then, it can be reasonably assumed that before modern technology of cancer 
treatment was available, the success rate of surgical treatment of any form of cancer in late 
stages was just as low, or most likely even lower, than the rates reported in 2011 and 2014 
throughout history.  
 Radiation therapy as treatment 
It was not until 1895 that the power of radiation was controlled and harnessed to treat 
cancer. In this year, German professor Wilhelm Conrad Roentgen presented a lecture in which he 
detailed X-rays he discovered (Markel). This discovery shook the world because of the potential 
applications of these rays. Within a year after the discovery of an X-ray, physicians began to use 
it in medicine to treat illnesses. A physician named Emil Grubbe, who hailed from Chicago, was 
one of the first physicians to put X-rays to the test (Markel). For two weeks, Grubbe decided to 
create his version of an X-ray, which he tested on his hand. After those two weeks, he developed 
burns on his hand due to overexposure to these rays. From this observation, Grubbe realized that 
X-rays had the power to damage tissues and cells significantly. Although it had detrimental 
effects on his hand, Grubbe wondered how it would affect cancerous cells that needed to be 
killed to prevent their explosive growth and to limit cancer progression. His first test patient was 
a woman named Rose Lee, who at 55 years old, had developed breast cancer again deep within 
her chest wall after a mastectomy. So, Grubbe suggested radiation therapy. Taking precaution to 
not harm the tissues and organs around the breast, Grubbe placed lead sheets around it to block 
any X-rays. This process was repeated for several days. However, Lee eventually died from her 
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cancer. Although this patient did not survive, Grubbe continued to perform radiation on other 
cancer patients, with a higher success rate over time. He eventually opened an X-ray clinic in 
Chicago (Markel). After this, radiation began to be used more frequently to treat cancers.  
Radiation therapy kills cancerous cells by damaging the DNA, or other macromolecules 
that compose the cell. In the course of treatment, however, radiation therapy created side effects 
that were as bad as or even worse than the symptoms of cancer. This led to the exploration of 
different types of radioactive isotopes and techniques to minimize the adverse effects of the 
treatment aimed to target cancer. By the 1920s, scientists had realized that fractionated treatment 
was better than a single dose (Gianfaldoni et al.) That is to say, it was beneficial for the patient to 
get lower doses of the radiation therapy over multiple exposures, rather than to have one long 
radiation treatment session. Throughout the 1900s, advancements in radiation therapy decreased 
its danger but also allowed physicians to use the therapy to treat deeper cancers more efficiently. 
In the seventies and eighties, scientists developed new devices that made radiation therapy more 
efficient. For example, the use of proton beams became more popular because it was successful 
in treating tumors and it was easy to control to target specific areas of the body more accurately 
(Gianfaldoni et al.) Nowadays, there are two main types of radiation used: electromagnetic and 
particulate radiation. Electromagnetic radiation uses X-rays and gamma rays while particulate 
radiation utilizes electrons, protons, and neutrons. Radiation can also be administered externally 
or internally, depending on the type and size of the cancer.  
Chemotherapy as treatment 
 Around the same time that radiation therapy was explored, chemotherapy was considered 
another treatment option that could yield beneficial results. Researchers realized that certain  
chemicals had the power to treat cancer. This interest in chemical therapy first began in the 
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1940s (“Evolution of Cancer Treatments: Chemotherapy”). During World War II, mustard gas 
was used against enemies in warfare because of its ability to create blisters all over the body and 
in the lungs as it was inhaled. When looking at personnel who had been exposed to the gas, it 
was found that the gas affected the bone marrow cells in a highly toxic way and significantly 
decreased their white blood cell count (“Evolution of Cancer Treatments: Chemotherapy”). At 
the same time, the United States army was studying this gas to find a way to make it more potent 
in warfare, but also to develop preventative measures to keep the United States’ soldiers safe. In 
the process, two pharmacologists named Alfred Gilman and Louis Goodman discovered a 
compound known as nitrogen mustard, which worked to cure lymphoma, or cancer of the lymph 
nodes (DeVita Jr. and Chu). To analyze its effect, they first induced cancer in mice models and 
treated them with the nitrogen mustard. After this proved to be successful, they injected the 
nitrogen mustard into a patient with lymphoma. The patient’s tumors diminished after multiple 
injections of nitrogen mustard. The results were published in 1946, and the use of nitrogen 
mustard to treat lymphomas became a popular form of chemotherapy (DeVita Jr. and Chu). The 
mechanism behind the compound involved damaging the DNA bases within the cancerous cells, 
effectively killing them. It became part of a class known as alkylating agents, which all work the 
same way as nitrogen mustard.  
After World War II, physicians and researchers began to look into other chemicals that 
could potentially work as cancer therapies. A pathologist named Sidney Farber discovered a 
compound called folic acid, which was crucial in DNA metabolism and had an effect on cancer 
(“Evolution of Cancer Treatment: Chemotherapy”). He artificially created chemicals that were 
structurally analogous to the chemical folate (a form of the vitamin B9) but were functionally 
antagonistic to it. These compounds inhibited the function of enzymes that used folate to be 
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activated and thus prevented DNA replication. After perfecting the chemicals and the process, 
Farber administered these chemicals to children who had lymphoblastic leukemia and found that 
the “antifolates” were able to restore healthy bone marrow in many of the children (DeVita Jr. 
and Chu; Mukherjee). This drug has undergone a few modifications and is known today as 
methotrexate, a compound still used in chemotherapies. A few years later, compounds extracted 
from plants began to be used to help treat leukemia patients (Mukherjee). These compounds 
were known as Vinca alkaloids, as they came from the plant Vinca rosea, and gained popularity 
as a chemotherapy in the sixties. Since then, more chemicals, both natural and artificial, have 
been discovered and created to treat different cancers in the most efficient way possible. In the 
past few decades, there has been a significant decline in the incidence of cancer-related deaths, 
due to the preventative measures taken by individuals and the advanced treatments made 
available to patients.  
Only recently have all the various treatments for cancer been used in conjunction to make 
the most effective treatment plan. These days, it is common for patients to be treated with a 
combination of the therapies mentioned, known as adjunctive therapy, to eradicate as much 
cancerous tissue as possible. Usually, for most cancers, after surgery is performed to remove 
tumors, chemotherapy or radiation therapy is used subsequently to remove any last traces of 
cancerous cells. Of course, the combination and type of treatments used depend on the 
individual, the type of cancer, and its progression. Cancer treatment has become a very 
individualized process, as each person reacts to each treatment differently.  The type and efficacy 
of that treatment also seem to depend on one other environmental factor: the region where 
individuals with cancer live.  
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Although many different treatments have been developed over hundreds of years to treat 
all types of cancer, every country differs in how they approach cancer treatment. Each country 
differs in policy, availability, and affordability that all influenced the treatment used there. 
However, this difference may stem from underlying ideas that have developed in the country’s 
population since cancer was first discovered thousands of years ago. Over the years, the people 
of various regions across the world have formed different perceptions about the importance, 
prevalence, and dangers of cancer based on the cultural, economic, and social ideals of the area. 
Main Question 
Different regions of the world are facing the treacherous effects of cancer at different 
rates and to varying degrees. In some areas, cancer is relatively controllable in most cases due to 
the availability of treatment and the lack of stigma against the disease. However, some countries 
and areas are severely threatened by the risk of cancer. The pertinent question at the forefront of 
this difference is why? Why is it that in one country, people are dying from cancer at alarming 
rates, and in others, cancer is being treated in astounding ways and more people are surviving 
than not? To answer this question, I find it beneficial to dive into the different regions and 
analyze the differences in cancer rates and treatments, and how regional perceptions of cancer 
might influence these differences. I first want to divide the analysis by country to see if there is a 
variation in understanding and treatment of cancer within regions as well as between regions, 
beginning with the broad region of Asia.  
Perceptions and Treatments of Cancer: Korea 
In Asia, I first want to look at Korea. Although I would like to examine both North and 
South Korea, more data seem to be openly provided from South Korea; therefore, the 
information that will be discussed is centered on South Korea. In 2017, Seoul’s office of 
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statistics reported that deaths from cancer had reached an all-time high that year: approximately 
80,000 people (Shim). Although it may not seem like much, the death count for cancer accounted 
for almost 30 percent of all deaths in South Korea. They also found that the most common and 
fatal forms of cancer were lung, liver, stomach and pancreatic cancer (Shim). Although these 
statistics seem alarming at first, it is essential to remember the demographic context of the 
country. South Korea’s population is growing increasingly older over the years. Because cancer 
most commonly occurs in older individuals, and since South Korea has an increasingly aging 
population, it makes sense that cancer deaths account for such a large portion of total deaths in 
the country. So, what does this mean for how people in South Korea perceive cancer? Is it a 
significant concern for them? Moreover, if so, this may lead to different treatments being offered 
for cancer patients in the region, compared to the other areas. 
Because the increase in cancer incidence is more closely correlated with the aging 
population of the country, rather than potential environmental and lifestyle changes among the 
Korean community, it would seem plausible that the majority of the Korean people would not 
have significant concerns or fears about the chance of developing cancer. However, a study 
conducted in 2014 surveyed 1,009 individuals through random sampling and found that the 
majority (59.5%) of people surveyed thought that they had a chance of developing cancer at 
some point in their life (Kye et al.) Another study, which was conducted in Korea in 2015 and 
surveyed 2,000 individuals with a history of cancer, found that only 19% of people had an 
accurate perception of the rate of cancer incidence (Kim, Soyeun et al.) About 50% of these 
people surveyed overestimated the survival rate for cancers that typically yield low survival 
rates, such as lung and liver cancers. These statistics showed that the Korean population was 
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relatively unaware of the incidence of cancer in their country, and this unfamiliarity might, 
therefore, contribute to the type of cancer treatments available to the population.  
 Certain demographic groups were also inclined to perceive cancer as a higher risk than 
other groups. Among these groups were females, younger people, individuals of lower income, 
and those with a history of cancer in their families (Kye et al.) These groups would make sense. 
For one, breast cancer is a form of cancer that is fairly common among women, and more rare 
among men, so it is plausible that the women surveyed had breast cancer in mind when 
responding to the survey. Young people also were able to perceive higher risk likely because 
they have more access to educational opportunities and are more aware of health risks. Put 
together, these two factors help to explain that only 30% of women knew that advanced age was 
a risk factor for developing breast cancer, and older women were less able to identify risk factors 
correctly (Kye et al.) Although women are generally more aware of the risk of cancer than men, 
the inclusion of older age might affect their awareness of developing cancer. Additionally, 
people of lower socioeconomic status perceived cancer as a higher risk likely because they 
experience more stressors in life such as unhealthy diets and environmental pollution among 
others (Kye et al.) Additionally, because people of lower socioeconomic status might have lower 
education level, they may feel more vulnerable to diseases such as cancer since they have not 
studied on or learned about the disease factors. What might have been most interesting about this 
study is that many people used a history of cancer in their family to gauge their risk of cancer; 
people who did have a family history of cancer were more likely to perceive cancer as a higher 
risk (Kye et al.) However, this was interesting because genetics is only one factor that could 
influence the chance of developing cancer in one’s lifetime; environmental factors and lifestyle 
changes and habits are much more influential on an individual’s likelihood of developing cancer. 
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This finding showed that the people surveyed, which most accurately represented the larger 
population of Korea, lacked sufficient knowledge to gauge their risk of developing cancer in 
their life correctly. Another interesting finding was that many people surveyed cited bad luck as 
a cause of cancer, which suggests an influence of faith and culture on their perceptions of cancer. 
It seems that many Koreans strongly believe in the power of luck on affecting their lives. The 
study also found that people who indulged in a healthier lifestyle, including regulated diet and 
exercise, were more aware of the risk of cancer (Kye et al.). After learning that the perceived risk 
of cancer varied among individuals, primarily based on differences in demographics, it is 
essential to ask how this affects the treatments offered in Korea and the willingness of the people 
to seek treatment for cancer. When individuals with cancer are more aware of the risk factors of 
cancer, it may lead to patients being more mobilized to get treatment, and in turn, to the 
government having greater initiative to invest in healthcare directed at treating cancer.  
Based on the previous research (Kye et al.), it seems that Koreans have a relatively good 
perception of cancer and most of its risk factors. Many Koreans acknowledged the importance of 
incorporating physical activity and a good diet on decreasing the risk of cancer, so Korean 
individuals with higher education were more predisposed to take an active role in controlling 
their lifestyle and participating in physical exercise. Those individuals with higher education and 
socioeconomic status were also more likely to have a healthier diet because they could afford it, 
and they tended to work out more often than those with lower education and lower economic 
status. Therefore, they did not perceive cancer as great of a risk as those with lower financial 
status and education. Those with a higher education level and socioeconomic status had a good 
idea about the importance of incorporating physical activity and maintaining good health on 
decreasing the risk of cancer; however, this still did not translate into the development of more 
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effective treatments in Korea. Even though the incidence of these various cancers was 
increasing, and many individuals were aware of the risk factors for developing cancer and their 
risks based on their economic and educational status, surprisingly, these two facts enough did not 
translate into their willingness to aid in the treatment of cancer in the clinical setting.  
 Clinical trials are a significant benefit in the progress of treating cancer by allowing 
scientists and researchers to test and manipulate different anti-cancer drugs and treatments and to 
analyze the results so that they can become more effective for patients. However, despite many 
Koreans knowing this, it did not make a significant difference on the willingness of Korean 
cancer patients to contribute to clinical trials. In a study conducted by Le et al. in 2012, 
researchers examined the perception of Koreans on participating in clinical trials. In the study, 
1000 patients with gastrointestinal/hepatobiliary cancer who visited the Samsung Medical Center 
in Korea were asked to participate in a clinical study for their specific cancer. Out of these 1000 
patients, only 675 gave their consent to participate. However, many of the patients were aware of 
the potential benefits of clinical trials. Lee et al. found that patients with a higher level of 
education and a higher socioeconomic status were more aware of the benefits of clinical trials 
than patients with a lower educational level and socioeconomic status. However, in the end, 
when the patients were asked to participate, factors that ended up translating into participation in 
the trial were recommendations from physicians, limited treatment options, and the potential of 
new anti-cancer drugs. In short, higher socioeconomic status and higher education did not 
necessarily correlate with greater willingness to participate in clinical trials. Even though the 
cancer incidence is increasing in Korea, and subsequently, the number of clinical trials to help 
combat the disease also increases, many people diagnosed with cancer are not willing to help 
further research through participating in cancer trials in Korea. On a scale called the Visual 
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Analogue Scale (VAS), the score that measures willingness to participate in clinical studies was 
a 5 for Korea; in comparison, many Western countries ranked higher than a 5 (Lee et al.) 
Perhaps, the lack of willingness to participate in clinical trials is preventing Korean cancer 
centers and researchers from furthering their studies and acquiring more information to combat 
cancer. As long as the willingness to participate in trials is not the majority, the incidence of 
cancer in Korea may increase steadily until the older population becomes more aware of cancer 
risk factors and clinical trials have enough willing participants to test potentially beneficial 
treatments. The question is, now, how that unwillingness of cancer patients to participate in 
clinical trials, despite their awareness of the risks for cancer, influences the treatments used in 
hospitals and cancer centers in Korea.  
Luckily, for Korea, their lack of willingness to participate in clinical trials did not majorly 
affect treatments available. A study conducted in 2017 by Kim and Yi surveyed 17 major cancer 
centers across the country to analyze their efficiency and efficacy for treating cancer. Twelve of 
the centers were national cancer centers, and the other five were major hospitals. According to 
the study, the number of cancer patients in Korea is increasing, largely due to the increasingly 
aging population of Korea. Also, it is reported that the number of long-term (five year) cancer 
survivors is increasing as well due to better detection and treatment methods and more frequent 
early screening for the disease (Kim and Yi). This means that the rise in the cancer incidence is 
most likely attributable to changing demographics of the Korean population, rather than lifestyle 
and diet changes. Having a larger elderly population allows for a higher percentage of cancer 
incidence in the population since cancer is more prevalent in people over 60. The problem with 
this is that most individuals (of all ages) surveyed did not recognize the importance of age as a 
risk factor for cancer even though this is the demographic group that is contributing the most to 
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the increasing cancer rate. Despite having better detection methods, if the elderly population is 
not aware of cancer and their risk factors, they will not be diagnosed as often as they should, and 
the rate of cancer incidence will continue to rise. I want to look into whether the elderly Korean 
population with cancer affects how cancer treatment is given, or if mainly younger individuals 
take advantage of the treatments offered since they are more aware of the risks of cancer than the 
elderly population. One of the central premises of many Korean cancer centers today is that 
prevention strategy and recovery methods besides the drugs themselves can improve the patient’s 
response to the cancer treatments.  
Many of the cancer centers in Korea focus heavily on recovery methods, which are 
applied generally to cancer patients, in addition to the actual treatments. For one, many of the 
cancer centers and hospitals offered physical activity programs, while some did not; 
interestingly, the highest frequency of these programs was found in the regional cancer centers, 
rather than in the major hospitals (Kim and Yi). This showed that Korea’s focus when creating 
the cancer centers and hospitals was to distribute equal resources throughout the country, rather 
than to focus treatment efforts in just the urban areas. It also showed that Korea sought to 
emphasize recovery in patients, since physical therapy after treatment likely allows patients to 
recover faster and better. This is important especially in the elderly population, in which 
recovery from gruesome treatments like chemotherapy and surgery is much more difficult. These 
centers also allowed Korean cancer patients in almost all parts of Korea to have access to proper 
treatment and recovery options. Many of the centers offered education programs to help Korean 
patients and non-patients become aware of the growing prevalence of cancer in the country, and 
to hopefully push Koreans to take more preventative actions to decrease their risk for cancer. It 
worked. Three different studies conducted by Mahon in 2000, Shin and Lee in 2003, and Li et al. 
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in 2013, all reported that health was managed better in the groups that participated in education 
programs about cancer prevention, pain was lower in groups that underwent pain education 
programs, and those that participated in education programs concerning diet, exercise and 
anxiety management before their surgical procedures reported better qualities of life after the 
procedures. This was all measured in comparison against a control group that did not engage in 
any programs (Kim and Yi). After looking at this, although the incidence of cancer is increasing 
in the Korean population, it appears that Korea is slowly but surely making its way to help 
patients manage their disease better. The recovery options available at such major cancer centers 
throughout the country ensured that every cancer patient had nearly equal opportunities to get 
high-quality treatment and receive education about cancer management.  However, there are still 
two major problems. Even though the centers have helpful resources (especially for the elderly) 
like post-treatment therapies, these resources are not being utilized effectively by the elderly who 
need them the most, since the elderly are not aware of their higher risk. Also, the lack of 
willingness for patients to participate in trials shows that many patients are still hesitant to 
contribute to cancer research and could, in turn, make progress in the treatment slower in Korea 
compared to other countries that had higher VAS scores.  These two factors can be improved 
through the education programs that are being offered as long as more individuals, including the 
elderly and least educated individuals, begin to take part in the programs. Education appears to 
be vital in changing awareness and in turn improving the treatments utilized and those available 
currently.  
Perceptions and Treatments of Cancer: India 
After looking at Korea and seeing how cancer perceptions in the population and 
demographic factors affect the availability and utilization of treatments, the question I want to 
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answer next is whether or not this same trend is found in other countries in Asia. Looking at 
India, I want to know if perceptions of cancer and its risks are the same, due to being in the same 
region, or whether there are differences in perceptions and treatments of cancer even with the 
vast area of Asia. India is a country where cancer seems to be negatively stigmatized often and, 
as a result, is not treated as well as in other countries. In my own experience, my mother’s aunt 
had breast cancer when she was in her sixties. However, she lived in a rural part of Central India, 
where there were not very many resources that she could afford. Because of this, she was not 
able to fight cancer through radiation, surgery, or chemotherapy and passed away in a painful, 
cancer-ridden manner. This situation, which I witnessed with my own eyes, made me wonder if 
many other Indians who suffer from any form of cancer experience a similar situation and what 
would contribute to the lack of widespread treatment available besides the weak infrastructure.  
Perceptions and Treatment of Cancer: Urban India 
In 2016, a study conducted by Elangovan and her team looked into how cancer 
perceptions affected the treatments and willingness of patients to get help in Chennai, India.  
Chennai, located on the Southeast coast of India, was home to 10,163,000 people in 2016 and 
was considered a megacity at the time. Approximately one million people in India have cancer 
each year, and 67.5 out of 100,000 individuals die from the disease. In the study, nearly three 
thousand patients who were interviewed represented various levels of society and different 
socioeconomic statuses. Among these patients sampled, 510 were actual cancer patients, 494 
were caregivers, 978 were college students, and 999 were participants sampled from the general 
public. The study also made sure to include participants from both the slum and the non-slum 
areas. It is important to note, however, that these categories did not necessarily divide into lower 
and higher socioeconomic status, respectively; for instance, there were participants who were 
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from the non-slum urban areas and also of lower socioeconomic status. The median age of all the 
participants was 28 years old, which is a relatively young age, leading to the possibility that the 
majority of the group would be aware of cancer and its treatment. However, this was not always 
the case. Over 50% of the respondents (53.5%) believed that radiation therapy entailed an 
electric shock (which we know is far from the truth) (Elangovan et al.) In general, among males, 
individuals with higher education and socioeconomic status, with personal experience of cancer, 
and of a younger age were more aware of cancer and its effects. Another shocking fact was that 
only about half of the individuals surveyed believed that surgery did not cause cancer to spread 
to other parts of the body. It seemed as if most individuals were unaware of the efficacy of 
treatments but had a relatively firm understanding of the risks of cancer and its deadliness. For 
example, 83.5% of respondents knew that cancer was not contagious, and 79.5% knew that it 
could be cured. Lastly, participants who were 60 years or older had the least awareness 
(Elangovan et al.) This is most likely because during their generation, cancer research and 
treatment were limited (even less than there was in 2016), so these older participants may not 
know about the medical advances in cancer treatment that have occurred.  
Additionally, one fault for the limited understanding of cancer in general among the 
Indian population in Chennai, compared to individuals of other countries within and outside of 
Asia, is the lack of effective programs to educate people about cancer and the lack of 
communication between patients and doctors. The study states that it is not common for the 
patients to ask the doctors questions about their illness, and also uncommon for the doctors to 
discuss the disease beyond the diagnoses out of fear that their patients would not be able to 
handle the prognosis well. Additionally, there is a lack of early treatment available for all 
individuals who have cancer, mainly because 75% to 80% of patients seek out treatment when 
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the disease has already progressed far (Elangovan et al.) This makes cancer even harder to treat 
and is why India should focus more on cancer education and preventative programs. Only about 
thirty years ago did hospitals in India begin to use the multiple forms of treatment in conjunction 
with each other to eradicate cancer - in short, the Indian healthcare system was relatively 
inexperienced with implementing the various forms of treatment and lacked the resources 
necessary to treat each patient with such individualized treatments. This lag in utilizing multiple 
forms of treatment must have resulted in part due to the stigmas surrounding cancer that many 
Indians have. For example, some believed cancer was brought upon by a curse, or it was 
untreatable, but most importantly, because it was talked about so little, even among doctors, 
many did not want to seek treatment.  
Perceptions and Treatment of Cancer: Rural India 
Since causation of the disease was not readily recognized awareness in such a major city 
in India, where cancer patients have the highest chance of receiving the best form(s) of 
treatment, I wanted to compare cancer awareness between Chennai and a rural city in India 
(much like the place where my great-aunt lived and passed), in order to see if there was a stark 
difference in how these patients were treated based on their perceptions about cancer. In a study 
conducted in 2014, Rai et al. looked at women in a rural city called Varanasi (home to over 3.6 
million individuals) and aimed to investigate their perceptions about cervical and breast cancer, 
which are two common forms of cancer among Indian females. The 700 female participants in 
the study were patients who were just recently diagnosed with either cervix or breast cancer and 
who were receiving treatment at Sir Sundarlal Hospital. Because the study was conducted in a 
more rural area of India, a majority of the patients were illiterate (59.7%), and only 4.3% of the 
participants had received a degree. 87.7% of the women were housewives. In terms of the 
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awareness of cancer, the results Rai and her team found were astonishing, but not surprising. 
97.3% of the women did not know the cause of cancer and many of them believed that 
microorganisms could cause the disease (about 40%). I assume that the definition of 
microorganisms, in this case, does not include viruses since they can be considered abiotic. The 
most interesting aspect of the study was the faith in religion that most of the patients had; 58.8% 
of the Indian females believed that a supernatural factor caused their illness, and 85.4% thought 
their cancer was an effect of a curse from God. Lastly, 71.3% of individuals consulted a religious 
counselor to help with their illness (Rai et al.) All these facts suggest that a majority of these 
women living in Varanasi in rural areas have great faith in God and think that God rules many 
aspects of their lives, including illnesses, in their eyes. Therefore, it is plausible that they do not 
turn to traditional medicine or have faith in it, because they have stronger faith in prayer to God 
to help alleviate their cancer. This may be a fundamental factor that explains why there are not 
many Indian women seeking out medical help for their treatment. The study showed that women 
only sought out formal medical advice from doctors when the cancer was causing severe damage 
or pain. This was similar to Chennai, where the majority of individuals waited until their cancer 
had progressed too far, leading to the high levels of cancer in late stages and difficulties in 
treatment. Their perception of cancer led people of both rural and urban India to turn to religious 
help first (due to their massive faith in God) before turning to medical professionals to accurately 
diagnose them. Their belief in religion over science may reflect the lack of education that is 
prevalent among Indian women, because they are unaware that cancer arises from biological 
processes, rather than chance through religion. Therefore, lack of knowledge and communication 
have slowed down cancer treatment in India, which needs to spend more on resources to educate 
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the public. Moreover, low availability and affordability of cancer treatment could have 
augmented the stigmas and misconceptions of cancer in India.  
Perceptions in India seem to have a profound impact on the treatments that are utilized or 
the willingness of patients to receive treatment for cancer. These perceptions are most likely 
molded by the culture and society in which they grew up. Indians who grew up in more rural 
areas, like Varanasi, are more likely to be less aware of the causes of and treatments for cancer 
than those who lived in an urban setting like Chennai. Because of this, they are not able to 
identify their cancer early on for effective treatment and are less likely to be able to afford the 
multiple treatments that become necessary as cancer progresses further without intervention. 
Also, because many Indian cancer patients believe so vehemently in God and are convinced that 
God has cursed them with cancer, they are more likely to leave their treatment and wellbeing in 
God’s hands, rather than to seek out treatment from a hospital.  
Approximately two-thirds of all Indian cancer patients die from the illness (Gulia et al.) 
This leads to a mortality-to-incidence ratio of 0.68, which is much higher than the ratio found in 
other developed countries, where the average ratio is 0.38. In urban areas, where more Indians 
are better educated than in rural areas, there is greater awareness about cancer, especially in the 
younger generation. As more people have degrees and are of a slightly higher socioeconomic 
status than those in rural cities, urban Indians have a greater awareness of cancer development 
and progression, as well as its treatment options. However, despite living in a metropolitan area 
over a rural area, there are still misconceptions centered around cancer, as seen with the high rate 
of the misconception that radiation therapy encompassed electric shock. This is likely due to the 
lack of comprehensive treatments available in India in general. Being a relatively impoverished 
country, India does not have much of the resources and money to offer cancer treatments to all 
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regions of the country equally (especially being such a large and diverse country). As a result, as 
mentioned earlier, combined treatments for cancer have only been around for thirty years, and 
they were most likely only affordable to and utilized by the higher classes. Also, there is a 
shortage of doctors specialized in cancer, or oncologists, for the number of Indian individuals 
who get cancer. There is only one oncologist in India for every 2,000 people who have cancer 
and only a total of approximately 1,000 trained oncologists in all of India (Gulia et al.) This 
means that anticancer therapies are not delivered effectively to all patients, and also contributes 
to the lack of distribution of equal resources for combatting cancer throughout India. The lack of 
money and resources, which include trained specialists who know how to administer these 
treatments, can potentially be attributed to the low education levels among the Indian cancer 
population, especially in rural areas.  
One factor that could significantly improve the cancer survival rate in India would be the 
implementation of education programs, like those available in the Korean cancer centers, that 
would serve to educate Indians, both patients and non-patients, about the risk factors for cancer. 
This might push Indians to seek out help for their cancer earlier on, rather than to wait until the 
disease has progressed too far. As we have seen, Koreans on average tend to have higher 
awareness about cancer and its effects, as well as the treatments available. This can likely be 
attributed to the frequency of high-quality cancer centers and hospitals distributed throughout 
Korea in both rural and urban areas, as well as the lack of strong influence of religion in their 
awareness of what cancer is, how it arises, and how it is treated. Additionally, education 
programs might help Indian cancer patients to manage their health better, as it was reported in 
many Korean cancer patients who attended the cancer centers with post-recovery treatment 
recovery options. Hopefully in future years, Indian governments will place more money in 
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improving the quality of treatments in hospitals throughout the country, as well as in investing 
money into educating the people of India about cancer and its risk factors to reduce the stigmas 
against cancer that prevent effective treatment.  
In Asia, East and Southern regions showed a stark difference in how individuals in each 
country perceived many factors about cancer, including its risk factors, causation, and treatment 
methods. In India, the people, both patients and non-patients, were more unaware of cancer than 
those in Korea. However, in Korea, there was still the elderly population that was less aware of 
the cause and treatment of cancer than the rest of the population. The younger individuals knew 
that cancer was treatable and that environmental factors influenced the cancer incidence in their 
country. Overall, Korea was also left in a better position in terms of treatment because clinical 
trials were being conducted in the country (although many Koreans did not want to participate) 
and their hospitals and cancer centers were more technologically advanced than the hospitals in 
India. Subsequently, they were able to educate Korean patients about the risk factors for cancer 
and to facilitate their road to recovery. The cancer centers and hospitals also worked to ensure 
that treatment was available to both rural and urban regions and that the general public was 
educated about the cancer incidence through their education programs. India had very little of 
this available; on top of lacking in technology and treatments open to the general public, little to 
no effort was made by the Indian government to educate the Indian public, leaving them in the 
dark about cancer, and possibly contributing to the cycle of Indians not willing to come forth to 
get a diagnosis or treatment until it was too late. Moving westward, Africa is a continent that has 
over 1.2 billion people, over one-eighth of the world’s population. Looking at this region, based 
on the infrastructure of the majority of the countries that make up the region, I predict that 
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perceptions of cancer will be inaccurate in a majority of African individuals, much like what we 
observed in India, and this in turn will likely affect the treatments that are offered to the public. 
Perceptions and Treatment of Cancer: South Africa 
Cape Town, South Africa is one of the most developed cities in South Africa, so one 
might assume that individuals might be more aware of cancer with regards to its risk factors and 
the treatments offered. In a study conducted in 2010, Maghboeba Mosavel decided to look into 
how mothers and their daughters living in Cape Town, South Africa perceived cancer and how 
their perception was influenced by their diverse cultures of Western, African, and Easter origins. 
The study involved 157 mothers and their 157 daughters (All subjects were mothers with one 
daughter), and the results were surprising. They found that when the mothers heard the word 
“cancer”, an overwhelming 69% immediately thought of death, and 43% of them immediately 
also thought of the negative consequences of having cancer, such as losing the ability to take 
care of and support their family. On the other hand, a fewer proportion of daughters (although 
not by much) had the same reaction to the word “cancer”; 50% also thought of death when they 
heard the word and 42% also thought of the adverse effects of having cancer. However, a 
majority of the daughters studied (66%) stated that their mothers had never talked to them about 
cancer or had never even mentioned the word to them. A small percentage of the daughters also 
claimed they did not know what cancer was. From these statistics, it is clear that South African 
women and daughters are fearful of cancer; it is something not commonly discussed or 
acknowledged out of this fear. This is partially due to their misconception that the illness cannot 
usually be treated but instead often results in death. Only 24% of the mothers recognized that if 
the cancer was discovered early enough, then it could be cured, but that if it were too late, the 
result would be death. This means that approximately 76% of the mothers sampled did not 
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believe in any treatability of the illness beyond the early stage, contributing to their fear of it. 
One positive aspect of the study was that a small percentage of the mothers (11%) thought that if 
individuals followed a healthy lifestyle and regularly attended checkups with a doctor, they could 
prevent cancer from worsening (Mosavel) Although this percentage is small, it shows that there 
are individuals who have realistic perceptions of cancer and its fate. This means that there is 
hope in improving the knowledge of cancer among South Africans through education at both 
familial and governmental levels. From our understanding of these perceptions, we can see how 
cultural beliefs that perpetuate throughout the South African community influence perceptions of 
cancer.  
I am convinced that through communication and greater education, the accuracy of 
cancer perceptions among mothers and daughters throughout South Africa can increase as they 
become more aware of the truth behind cancer. The relationship between mothers and daughters 
could be used as an essential tool for educating future generations on the reality of cancer. From 
the study, we saw that the daughters had a slightly more accurate perception of cancer than their 
mothers, and this generational difference and familial connection could be used to educate the 
mothers about cancer. 80% of daughters studied showed a willingness to talk to their mothers 
about the benefits of a Pap smear (Mosavel). If South African mothers took advantage of this 
screening through their relationship with their daughters, it might improve the outcome of many 
South African women with cervical cancer and may push them to seek out screening and help 
earlier. This is extremely important in South Africa because the country has free resources 
available to women to screen for cancer. For women who are thirty years of age or older, pap 
smears are freely offered to them to test for cervical cancer. However, even though this initiative 
is already implemented, the fear mothers have of cancer is preventing them from seeking out 
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early diagnoses. This fear stems from also witnessing in their community other women and men 
who have cancer, and these negative experiences affect these women more than the benefits of 
early diagnosis and treatment (Mosavel). The positive effects of early screening and routine 
checkups for South African women should be made more visible through education and 
communication to offset the unnecessary fears that can interfere with early diagnosis and 
treatment. This could be done by visiting a doctor regularly, as well as learning how to examine 
their bodies. Just as in India, education programs implemented by the government throughout the 
country and other parts of Africa could be extremely beneficial in adjusting the common 
misconceptions many women, men, and children have about cancer and may serve to mobilize 
masses to get help early on before it gets too late. This could, in turn, over generations, help to 
mitigate the fear of cancer once they see the benefits of early diagnoses and regular check-ups 
for themselves, their families, and their communities. One interesting factor was that a small 
portion of the women in the study correctly recognized that cancer was a genetic illness and that 
a healthy lifestyle could decrease their chances of getting cancer (Mosavel). Many of the 
daughters cited drinking and smoking as being significant factors in increasing the risk of cancer 
in South African individuals. Women’s organizations that promote awareness of cancer could be 
incentivized to enhance communication among more women. However, as for now, it seems as if 
fear is ingrained in the perception of cancer, at least for most women, and this fear is being 
handed down like genes from mother to daughters, perpetuating misconceptions about cancer 
and preventing women, and potentially their daughters, from being brave enough to seek out help 
early on, even though treatment and early screening are available to them.  
Although pap smears are available for free for South African women, this does not 
necessarily translate into complete care and treatment for cancer in African individuals once they 
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are diagnosed. It is known that many individuals in South Africa are not willing to get screened 
due to the fear of being diagnosed with cancer, but what does this mean for the individuals who 
have been tested or diagnosed with cancer? How do they go about treating it? It is possible that 
the perception of cancer, coupled with the economic situation of the country, influences the 
treatments available for cancer patients and their ability to obtain complete treatment that would 
eradicate their cancer. It is important to remember that in South Africa, from the study conducted 
by Mosavel, mothers and daughters had some awareness about cancer and the possibilities of 
screening for early detection of cancer, but in cities and countries that are much less developed 
than Cape Town and South Africa, respectively, the opportunities for treatment and education 
are likely more challenging to obtain.  
An article from November of 2018 published by CNN mentions the difficulties of getting 
any treatment for cancer in Cape Town, South Africa. The article follows a 31-year old woman 
named Anne Borg who was living in South Africa and was struggling to find doctors who would 
diagnose her promptly (Gbadamosi). For many weeks on end, she would have to wait in line at 6 
A.M. just for a chance to consult with a doctor who could test her for the possibility of breast 
cancer at her local government-run hospital. Like Anne Borg, many of the other South Africans 
she encountered in line were also medically uninsured and could not afford to get insured in their 
lifetime. In general, Borg discovered that it was hard for many people in Cape Town to afford 
the multiple tests needed to check for various cancers, and only those who could afford them 
could get diagnosed privately. This made up a tiny portion of South Africans who had more 
wealth than the majority of the population. At the public hospital, it was common to observe long 
lines that were full of many people, sometimes as many as thirty people, waiting to undergo a 
test or receive a diagnosis for their cancer as well. It took Borg six months to get her diagnoses 
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from the time she was finally able to meet with a doctor, and by the end of those six months, it 
was too late: her cancer had progressed to the point that required mastectomy (breast removal 
surgery). Borg was hopeless that she would ever be able to have the surgery in time, after 
considering how much time had passed since she first met with the doctor until she received the 
diagnosis. However, Borg found out about a project called Project Flamingo that would grant her 
the surgery faster, and two weeks after her meeting with a Project Flamingo member, she was 
able to get a double mastectomy (Gbadamosi).  
Although this article was specific to breast cancer, it is safe to assume that the timeline 
between diagnoses and treatment would be similar for different kinds of cancer in South Africa 
because breast cancer was so familiar and could often be treated successfully. At many of the 
hospitals in Cape Town that offered breast cancer diagnoses and treatment, it would take an 
average of 8.5 months to receive a cancer diagnosis once individuals had met with their doctors 
(Gbadamosi). On weekends and holidays, most hospitals and clinics are closed, contributing to 
the lack of productivity in the hospitals in handling the thousands of patients that come in hopes 
of getting a diagnosis as soon as possible. However, Project Flamingo wanted to change that. 
Project Flamingo, which was created by a surgeon Dr. Roodt, aimed to fix the waiting problem 
that is commonly found in many of these clinics in South Africa. The project recruits surgical 
professionals and volunteers, and raises funds, all of which help to increase the efficacy by 
minimizing the timeline between the patient visit, diagnosis, and treatment (Gbadamosi). One 
way to address the long waiting time is to increase the number of cancer centers to provide better 
access to all of the individuals who need surgeries or other treatments to survive. Doctors in the 
program strive to decrease the wait time it takes to find out about a diagnosis for breast cancer 
specifically to 30 days at the most. However, in regard to the project’s success, surgeon Dr. 
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Sarah Rayne says, “Even in Johannesburg, they fail to reach that target more than 60% of the 
time” (Gbadamosi). This lack of ability to reach their target speaks more about the state of 
cancer treatment in South Africa than the efficacy of the project; it tells us that surgery is rarely 
the simple solution to the bigger problem of cancer.  
The goal of Project Flamingo, unfortunately, implies that in many clinics and hospitals, 
surgery is the main, and sometimes only treatment used to manage cancer, especially breast 
cancer, which is commonly treated with mastectomies. One of the most shocking facts in the 
article is that only five or six centers in all of South Africa offer chemotherapy and half of the 
radiation therapy equipment in all of Africa is located in South Africa (Gbadamosi). This clearly 
demonstrates low accessibility and availability of treatments throughout all of Africa because if 
the two largest cities (Johannesburg and Cape Town) in South Africa, and some of the most 
technologically advanced cities in all of Africa, are struggling to provide chemotherapy and 
radiation therapy, there would definitely not be enough resources to deliver these treatments in 
other countries that are much more rural and underdeveloped. Even though other African 
countries and cities may have surgery available in some of the hospitals, multimodal therapies 
are more effective in treating many cancers. Expedited steps in the process that lead up to 
surgery or any other treatment is critical in South Africa, but alternative treatment methods need 
to be made more accessible for people with advanced stages of cancer to increase the survival 
rate. 
As we move to more rural areas, the problem of inadequate cancer treatment gets worse. 
As was seen with India, many hospitals in Africa are short staffed, especially in rural regions of 
Africa, and these hospitals face the same problem of having few specialized cancer doctors. In 
South Africa, there are only six properly trained surgeons for every 100,000 people, in contrast 
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to the United States, where the ratio of surgeons to people is six times that in South Africa 
(Gbadamosi). Even in other African countries like Nigeria, which has Africa’s largest economy, 
there is only one surgeon for every 100,000 people. The saddening ratio only decreases further as 
we move to more rural, underdeveloped countries. In Chad, there is one trained surgeon for 
every 1,000,000 people (Gbadamosi). Project Flamingo addresses this problem by having a team 
of surgeons and volunteers with the same goal of offering efficient care, but more programs like 
it need to become mobilized to help decrease cancer incidence in the more rural, underdeveloped 
countries across Africa.  
 It is clear that perceptions in Africa about cancer are generally inaccurate, and only 
become more misconstrued as one moves to more rural regions of Africa, and the lack of 
efficient treatment only fuels this fire. These perceptions of cancer are due to fear of the 
diagnosis, which ultimately prevents many individuals from reaching out and seeking help from 
medical professionals early enough, as observed in the mothers and daughters surveyed in Cape 
Town. However, these perceptions are not the only problem. In Africa, because many people are 
afraid of cancer, they wait too long to go to the doctor, and once they visit the doctor, a relatively 
long time has passed before patients get their diagnoses back. By this time, many individuals 
must undergo major surgeries, or may not be helped at all by surgery due to inevitable cancer 
progression.  
Additionally, Africa lacks the resources to treat most cancers holistically, and the problem 
only worsens as one moves to more rural areas with weaker economies and incapable 
governments that cannot provide the money and infrastructure necessary to help treat cancer 
patients sufficiently. One way to address this problem is to start with education and advocacy 
programs among Africans so that their fear, which stems from misconceptions of cancer, does 
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not prevent them from seeking out preventative measures that will decrease their chances of 
developing life-threating cancer. We see the need for public education in shaping the perception 
and raising awareness of cancer in South Africa as well as in India, two countries with 
developing infrastructures. 
I noticed a difference in cancer perceptions between individuals in underdeveloped and 
developed countries, which generally affected the treatments that were offered. We saw that 
Korea was relatively prepared for treating cancer patients, most of whom were well informed 
about the procedures and outcomes involved in cancer treatment, whereas India and South Africa 
faced barriers formed by an individual’s beliefs or notions that made cancer treatment more 
difficult. Moreover, in those countries with weaker economies and lower infrastructures, there 
are limited technologies and resources to support treatment tailored to each patient. Surgery, a 
treatment most commonly practiced in underdeveloped countries, is not ideal for patients who 
wait until their cancer is in a later stage. To tackle this problem, the common perceptions about 
cancer in these countries need to be changed to promote proactive behaviors in terms of taking 
charge of their diagnosis and treatment early on. This will prevent their cancer from 
metastasizing to a deadly point and reduce cancer mortality, and can also make treatments more 
effective and affordable. As mentioned earlier, this is why education programs are essential in 
improving cancer survival rates in developing countries, as much as advanced and personalized 
treatments are. Countries with innovative cancer centers and various therapy options, like Korea, 
Europeans countries, and the United States are better able to take care of cancer patients and, in 
turn, reinforce an environment in which individuals in the populations are more aware of the risk 
factors for cancer and have more accurate conceptions of cancer. 
 38 
Another trend that I noticed between all the regions and countries analyzed so far is the 
difference between cancer perception in young adults and that in older adults, either women or 
men. In general, the younger population is more aware of the risk factors for cancer, whereas 
elderly individuals are less aware and have more misconceptions about cancer. This is most 
likely due to a technological and educational gap between the generations that have come to 
experience cancer. In other words, the older generation grew up in a time when many cancer 
treatment options were not readily available, and these treatment options, like the ones 
mentioned earlier in the first half of the twentieth century (primitive forms of radiation therapy 
and chemotherapy), were less effective than the current treatments that are more technologically 
advanced. Additionally, the older population, who has limited understanding about cancer 
medicine and treatment, is less willing to participate in screenings and trials that could 
potentially help themselves or the general public. This leads to increased fear of the illness and 
unwillingness to visit hospitals for diagnosis and treatment. I suspect that this trend will be 
consistent throughout most of the regions we look at, especially in places with lower education 
levels than first-world countries and superpowers. I want to next look at countries that we 
frequently associate with being technologically advanced, and countries where the history of 
cancer was well documented and studied and cancer treatment was at the forefront of 
advancement, beginning with the countries of Europe. 
Perceptions and Treatment of Cancer: United Kingdom 
The United Kingdom is a first-world country with a traditionally stable economy 
(although this is changing now) and a well-educated population. Approximately 35% of all 
people living in the United Kingdom have a degree - about 10% more of the community than the 
European average (“Average Education Levels”). Additionally, there is a mandate that states that 
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all children in the United Kingdom must attend full-time education until the age of sixteen. This 
has resulted in a high proportion of young people who seek a degree from a university (“The 
British Education System”). The United Kingdom is a relatively industrialized country, but its 
economy is slowly deteriorating. Although the United Kingdom is more developed than 
countries like India and Nigeria, the degree of industrialization may not always correlate with 
that of cancer awareness. Despite the relatively high education level of the United Kingdom, 
there is still a disparity in education about cancer and its risk factors in the United Kingdom. One 
study from the British Journal of Cancer gathered data on public perception of cancer among 
British adults, specifically. The study states that cancer patients in the United Kingdom “tend to 
present with more advanced disease and have poorer survival rates than many of their European 
counterparts” (Robb et al.) Considering the developed status and the level of education in the 
United Kingdom, it is curious as to why the effect of cancer is more devastating in the United 
Kingdom than other countries surrounding it. It is possible that the reason for the more advanced 
disease presented by many United Kingdom patients is partly due to their education levels, 
which could affect the course and outcome of treatment by influencing their perception of 
cancer.  
 Education levels, which we can assume are usually reflected by socioeconomic status, 
can have a profound impact on cancer awareness, and this trend is seen among the British 
population. In the previously mentioned study, 2208 adults were examined to measure 
knowledge of cancer in Britain. To do this, researchers used a scale known as the cancer 
awareness measure (CAM) scale, which utilized both open-ended and close-ended questions 
(Robb et al.) The individuals sampled were from different demographic groups, varying in age, 
ethnicity, education, and occupation.  Many different conclusions about people’s perception of 
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cancer in Britain across different demographic groups were drawn following the study. British 
individuals of lower socioeconomic status and ethnic minorities were more willing to reach out 
to a doctor to screen for cancer than those of higher socioeconomic status and other ethnicities. 
Although this is surprising and seems contradictory, many of these individuals cited that they felt 
that few barriers prevented them from seeking help. These individuals, mainly those of lower 
socioeconomic status, were found to have more significant emotional barriers (the main barriers 
cited) than those of higher socioeconomic status. Although restrictions were mentioned, in most 
cases, these emotional barriers did not always prevent individuals from seeking out professional 
help. One of these emotional barriers was the fear of the doctor’s diagnosis; people in the study 
claimed that this barrier could prevent them from getting help so that they could avoid finding 
out the truth, especially if the prognosis was poor.  Another barrier to seeking treatment was a 
busy schedule, which was cited most commonly by people of higher socioeconomic status. 
However, the same group of individuals with higher socioeconomic status were willing to see a 
doctor for a cancer diagnosis or check-up sooner rather than later, most likely because they could 
afford the treatments associated with the diagnosis (Robb et al.) This likely correlates with 
education level; those who can afford the results of diagnosis are those who are more educated 
about and aware of the benefits of early screening and treatment. We also saw that people of low 
SES were willing to see a doctor earlier on, most likely because they cannot afford the expensive 
treatments necessary to treat the disease that has progressed too far, and not necessarily because 
they are educated about early cancer detection and treatment. Another barrier to seeking 
treatment was the desire not to waste the doctor’s time. Almost 40% of the interviewees, both 
men and women, revealed that they did not want to waste their doctor’s time for a test for cancer 
or routine check-up, so they would delay visiting a doctor (Robb et al.) Additionally, one of the 
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highest barriers cited was the difficulty of scheduling a doctor’s appointment, deterring their 
desire to check for cancer. Overall, all of these emotional and physical barriers to finding 
treatment resulted in more considerable delay in visiting the doctor. However, one positive 
finding came out of the study. Most of the interviewees claimed that they would seek out help 
from a doctor if they noticed a warning sign of cancer, such as a lump or mole. Researchers also 
found that individuals who were more aware of the warning signs of cancer were more likely to 
visit a doctor faster (Robb et al.)  
In contrast, another concerning aspect of the study was that age had a significant impact on 
the awareness of cancer of the British population. They found that the oldest age group (those 
who were over 65 years old) had the most trouble recognizing the warning signs (Robb et al.) 
This creates a problem for decreasing cancer incidence in Britain because most cases of cancer 
occur in this age group specifically. If individuals in the oldest age group are not able to identify 
the warning signs, then cancer would progress its course and become difficult to treat. Another 
interesting age-related factor was that awareness of cancer was lowest in the youngest age group 
(those around 16-24 years of age) in one aspect: recognition of warning signs. British individuals 
between 16 and 24 years of age were least able to recognize the warning signs of cancer when 
presented with different symptoms (Robb et al.) This could potentially be because this younger 
group has not yet experienced cancer as closely as other older individuals have. However, this is 
still a big problem because it demonstrated that the younger, growing population is not getting 
enough education about the reality of cancer and its risk factors before they reach an age more 
vulnerable to the disease.  
Even though the United Kingdom is a relatively industrialized, educated country 
compared to other underdeveloped countries such as those in Africa and India, there is still a lack 
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of accurate perception about cancer, particularly in the younger and older populations. While 
some individuals are not motivated to go to the doctor and allow cancer to progress, others 
cannot even determine the warning signs for the illness. This, in turn, could explain the lower 
survival rates from cancer and greater progression of cancer in cancer patients in the United 
Kingdom compared to those in other European countries. One fundamental reform or initiative 
that could potentially change this reality and reduce misconceptions about cancer throughout the 
United Kingdom is the implementation of education and advocacy programs. Education 
programs are critical in making individuals more aware of the reality of cancer and turning fear 
of cancer into proactive actions for prevention and treatment. As was pointed out in the study, 
the lack of awareness about cancer is evident in the oldest and youngest populations. They need 
to know what actions are necessary for treating cancer and improving survival rates. Older 
people need to be educated about their increased risk for cancer so that they are mobilized to go 
to the doctor for a diagnosis, especially when they experience warning signs, to prevent cancer 
from becoming too difficult to treat.  
Also, the same education can target the youngest population. Even though so many 
young people are receiving decent education, they are not well informed enough about cancer to 
develop realistic and accurate perceptions to prevent or delay the disease. Therefore, education is 
vital across all demographic groups because it will help individuals across the United Kingdom 
understand warning signs of cancer and overcome any barrier to seeking early treatment. Instead, 
visiting the doctor should mitigate their fear because it will allow the British people to take 
charge of their diagnoses early for better management. It is good to know that the British people 
of lower socioeconomic status and ethnic minorities are willing to go to the doctor earlier for 
screening, but this is something that should be reflected in people of all socioeconomic statuses 
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and ethnicities. As we have seen, education is a reoccurring theme across all countries of 
different developmental stages and economic growths because it is vital to changing the 
perception of cancer from unnecessary fear to attainable recovery.  
Perceptions of cancer among individuals in the United Kingdom are relatively low for a 
country with the given economic status and the apparent education level of the people. The delay 
in visiting the doctor to check for cancer seems to have a profound impact on the survival rates 
and the severity of the disease in individuals with cancer. The next intriguing question is how 
United Kingdom hospitals treat their patients who often exhibit advanced stages of cancer. One 
might think that an economically stable country like the United Kingdom has the resources to 
treat these individuals and provides access to high quality treatments for cancer. Additionally, 
many advancements in cancer therapy were developed in Europe, where we expect to find many 
countries at the forefront of cancer treatment technology. However, if this is the case, why is the 
survival rate from cancer lower in the United Kingdom than in other European countries? I want 
to know how the country deals with its cancer patients and ask whether, if at all, the British 
perceptions of cancer or the efficacy and efficiency of available treatments influence the high 
cancer rate.   
Before we ask if the availability and utilization of treatment in the United Kingdom can 
explain or correlate with the low survival rate of cancer, it is interesting to point out the British 
perception on their health care in terms of cancer therapy. A study conducted by Ramers-
Verhoeven et al. in 2013 looked at different countries across the world and compared their 
perspectives on cancer treatment and its advancement in their own countries. The United 
Kingdom was one of the countries where individuals were asked to rate their satisfaction level of 
cancer treatments. They found that the United Kingdom shared the highest satisfaction levels in 
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terms of the progress made in cancer treatment over the past 20 years. Many of the United 
Kingdom individuals interviewed also thought that development in cancer treatment costs much 
less than it did (estimating around 100 million euros or less), when in fact, the cost of 
advancement in cancer treatment was in the billions of euros (Ramers-Verhoeven et al.) These 
findings might explain why people living in the United Kingdom still have hope in cancer 
therapy even though their cancer survival rates are lower than the rest of Europe. Why do 
patients in the United Kingdom delay their visits to the doctors when they think the country has 
been making progress in cancer treatment? For one, the fear factor seems to overshadow their 
faith in the country’s ability to fight cancer and causes a delay in seeking help and diagnosing 
their disease. Additionally, the study found that 70% of the United Kingdom individuals were 
concerned that progress in cancer development would slow down due to the failing economy of 
the country (Ramers-Verhoeven et al.) Although people of the United Kingdom report high 
satisfaction levels in progress made in cancer therapy up to now, they fear that the slowing 
economy of their country would hinder the development of more effective treatments (Ramers-
Verhoeven et al.) Also, the underestimation of the spending put towards cancer research and 
development of therapies may reflect their ignorance of the complexities of cancer treatment. 
Now, I want to know if the United Kingdom’s true investment of resources reflects the public’s 
perception of the current status and prospect of cancer therapy.  
Contradictory to the highest satisfaction levels in the progress their country has made in 
terms of cancer treatment development, the United Kingdom actually has one of the lowest 
shares of its gross domestic product (GDP) spent on health care as of 2014 compared to other 
countries in Europe.  In 2014 specifically, the United Kingdom spent 9.1% of its GDP on health 
care, but the average amount spent by all other European countries was 10.1% (Davis). We could 
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interpret this to mean that the United Kingdom spent less on cancer diagnoses and treatment per 
person compared to other countries. Although the difference in the investment of GDP in 
healthcare between the United Kingdom and other European countries might not seem much 
(only about 1% difference), it can explain in part the low survival rates of cancer patients in the 
United Kingdom compared to other European countries. The GDP that each country spends on 
health care accounts for all the surgeries, chemotherapies, radiation therapies, and medicines that 
are needed for cancer treatment; so, when the United Kingdom spends less money on these 
treatments, the availability and development of cancer treatment for the population will be 
hindered to contribute to low survival rates. For example, the five-year survival rate for colon 
cancer was 58% across Europe (on average), but in the United Kingdom, this survival rate was 
only 52% (Davis). The United Kingdom is also lagging behind other European countries in the 
“uptake of new cancer drugs,” or the willingness to use new drugs developed for cancer therapy 
(Davis). This can be attributed to the low investment in health care cost and subsequently 
reduced visibility of new drugs, placing a significant barrier in the development of cancer 
treatment in the United Kingdom. In addition to educating patients and the general public to 
reduce their fear and to promote early diagnosis and treatment, the United Kingdom needs to 
increase spending on cancer treatment as well as development and marketing of new drugs for 
better results in delaying and ameliorating the course of the disease.  
We have seen how individuals representing different demographic groups in the country 
perceive both cancer and its treatment, and how government efforts and resources can raise 
public awareness and improve cancer therapy. Next, I want to analyze the relationship between 
different perceptions of cancer, based on age and the course and cost of treatments. In 2016, 
there were 1.8 million people who had been diagnosed with cancer in England, and researchers 
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predict that this number will continue growing each year (Laudicella et al.) One study analyzed 
thousands of patients, over the age of eighteen, who lived with cancer (colorectal, breast, 
prostate, and lung) in England and estimated the costs involved in their treatment and diagnoses. 
These costs were obtained from all English cancer registries and hospital databases available. 
The costs were also then separated into three categories: incidence costs, prevalence costs, and 
phase of care costs. According to the study, incidence costs are the “costs of delivering care to a 
homogenous cohort of patients fixed in the year of their diagnosis and followed up for a certain 
number of years” (Laudicella et al.) and only includes those patients who survived from the 
previous year. A prevalence cost is a snapshot of the total costs delivered to all patients in a 
calendar year”. Lastly, phase of care costs broke up the costs for patients at different stages of 
care. The researchers then separated these costs for two groups: the younger age group, 
comprised of individuals aged 18 to 64 years old, and the older age group, comprised of 
individuals aged 65 years and older (Laudicella et al.)  
Most of the cancers observed had the highest incidence in the older age group; breast 
cancer was the only cancer in which the majority of occurrences was found in the younger age 
group (Laudicella et al.) Although cancer incidence was mostly higher in the older age group, 
patients in the younger age group was more likely to receive cancer treatment in the form of 
surgery within twelve months of their diagnosis. These patients also had a higher chance of 
survival after their cancer diagnosis. Prior to diagnosis, the costs for cancer care were higher for 
patients in the older age group, but this switched during the year of diagnosis. It was shown that 
the costs for care in the year of diagnosis was 17,241 euros for patients in the younger age group, 
but 14,776 euros for patients older than 65 in the case of colorectal cancer. For breast cancer, the 
costs in the year of the diagnosis were 11,109 euros for the younger age group and 7,788 euros 
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for the older age group. For patients with prostate cancer, in the year of diagnosis, patients in the 
younger age group spent 5,171 euros, and patients in the older age group spent 4,699 euros. 
Lastly, for patients with lung cancer, patients in the younger age group spent 12,083 euros in the 
year of diagnosis, and patients over 65 spent 9,061 euros (Laudicella et al.) Although a higher 
incidence of all these cancers, except breast cancer, was found in the older cohort, the younger 
spent more on the incidence costs. So, what does this mean?  
These statistics reflect what we know about cancer treatment already and make sense: 
age-based, different perceptions of cancer can affect the treatment course and its outcome. Prior 
to diagnosis, it is reasonable that the older age group paid more for medical care and check-ups 
because they are likely to have more frequent visits to the doctors and incur other medical costs 
for health conditions that are more prevalent with their age. However, the shift to higher costs 
among the younger age group during the first year of diagnosis can also be explained. As 
mentioned earlier, the younger age group is more likely to get surgery and potentially other 
cancer treatments and drugs during the first twelve months after diagnosis; this implies that the 
cancer care costs for the younger age group will be higher than the costs for the older age group, 
who receives fewer surgeries and treatments during the initial period. Also, another potential 
reason could be that some patients in the elderly group cannot afford the treatments, especially if 
they are retired or if their cancer has progressed too far to benefit from treatment. 
 Moreover, older patients may be more reluctant to spend much money on themselves 
when their remaining life is relatively short (whereas younger patients are more invested in 
recovery). This may also help to explain why the elderly population is relatively unaware of the 
warning signs of cancer. The elderly may not have many opportunities to learn about the disease 
and its treatment, or they have another disease that complicates their health and preoccupy their 
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life. However, the study also found another shift after five years in the prevalence costs. Much of 
the prevalence costs at the five-year mark were attributable to age and were higher in patients 
older than 65 years of age, except for breast cancer because it is most prevalent in the younger 
age cohort. This increase in cost in the older group in the fifth year after diagnosis is most likely 
because younger patients need less care following treatments unlike older patients, especially if 
the cancer is found at an earlier stage. Younger individuals can potentially bounce back from 
treatments faster and handle consistent, and sometimes painful, treatments better, decreasing 
their dependence on the treatments, and in turn, reducing the costs. The group of cancer patients 
aged 65 and older, however, most likely need to continue cancer treatments among other health-
related treatments and expenses, especially if their cancer is more advanced in stage. These costs 
can accumulate quickly and can potentially explain why their five-year prevalence costs are 
higher.  
Overall, 1.5 billion euros were spent on four cancers (colorectal, breast, prostate, and 
lung) in Britain in 2010 (Laudicella et al.) Despite the difference in age groups and the 
distribution of cancer costs over time, based on the previous study, it is clear that people of the 
United Kingdom are not fully aware of the current status of cancer therapy in terms of treatment 
efficiency (reflected in the cancer survival rate) and innovation (reflected in treatment 
development). This is why I stress education across the board regardless of the country or 
demographics of individuals. Education of older populations could help to mobilize them so that 
cancer does not so quickly reach a deathly stage, which would increase the cost of treatment and 
care and compromise the quality of life. By educating the elderly, they can get diagnosed and 
treated earlier for quicker recovery and a longer life span. Education of the younger groups is 
essential as well so that they do not perpetuate the excessive fear of cancer diagnosis and cancer 
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costs to future generations, but instead rationally tackle the disease by following effective 
treatment plans, especially for cancers that are prevalent in younger age groups (e.g. breast 
cancer). The perception of cancer and its treatment success rate are relatively low in the United 
Kingdom compared to other European countries, but it would be interesting to make a direct 
comparison with another country. France is a European country that is advanced economically 
and technologically, as well as infrastructurally. Do the people of France have different 
perceptions of cancer and cancer treatment than the people in the United Kingdom, or is the 
French population more aware of the reality of cancer and its treatment? How does this translate 
into the cancer therapies that are utilized in the country? 
Perceptions and Treatment of Cancer: France 
France is an economically sturdy country in Europe, and both France and the United 
States are considered first-world countries. Still, France is not immune to the effects of cancer; in 
fact, the cancer incidence of France is even higher than that of the United Kingdom. In France, 
344.1 out of every 100,000 people were diagnosed with cancer, whereas in the United Kingdom, 
319.2 out of every 100,000 people were diagnosed with cancer in 2018 (“Global Cancer Data by 
Country”). Interestingly enough, out of the top ten countries with the highest cancer rate, not one 
of them is from Asia or Africa. As with the United Kingdom (ranking number 13 in cancer 
incidence), France (ranking number 7 in cancer incidence) also faces a struggle against cancer 
(“Global Cancer Data by Country”). One might ask if such a high incidence of cancer in France 
could be attributed to behavioral or environmental factors.  A study from 2016 looked at how 
French individuals perceive cancer and its risk factors and if their perception correlated 
significantly with socioeconomic status. Common risk factors for cancer were organized into 
three overarching categories: behavioral, environmental, and psychosocial (Peretti-Watel et al.) 
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Behavioral risk factors included smoking, drinking, and sun exposure, among other actions that 
humans consciously partake in despite the potentially harmful consequences. The environmental 
risk factors, such as the chemicals in food and air pollution, were ones that, by and large, 
individuals had little to no control over. The last group of risk factors was psychosocial factors, 
such as past traumatic experiences or stress, which affected the minds of participants. After 
gathering data from 3359 individuals of age 15 up to age 75 (with a 59% participation rate), 
researchers found that 32.4% of participants thought that cancer was “not avoidable.” However, 
when the researchers controlled for the effect of demographics on the results, such opinion was 
less frequently held by people who emphasized that certain behavioral factors increased the risk 
of cancer; they were more likely to think that cancer was avoidable (Peretti-Watel et al.) This 
suggests that some French people recognize that certain behaviors, like drinking and smoking 
that have adverse effects on health, can increase susceptibility to cancer. Their awareness of 
behavioral risk factors leads them to think that cancer is partially preventable at will. On the 
contrary, people who leaned towards the environment as a significant risk factor for cancer more 
frequently took on the viewpoint that cancer was unavoidable (Peretti-Watel et al.) Since 
environmental factors are more difficult to predict and manage than behavioral factors, people 
who perceive environmental factors as the major risk factor would be more likely to accept the 
inevitability of cancer. In terms of socioeconomic status, people with higher socioeconomic 
status often considered behavioral and psychosocial factors as the major risk factors for cancer, 
whereas French individuals with intermediate socioeconomic status often regarded 
environmental factors as the major risk factors. Another exciting find of the study was that many 
people who emphasized the environment as a significant risk factor admitted to being daily 
smokers (Peretti-Watel et al.) This reflects the idea that people of higher socioeconomic status 
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tend to think they have better control over their health due to their status. This may be because 
they can afford better health care or that their work and personal lives are more demanding 
intellectually in nature. In any case, people who recognize behavioral and psychological factors 
as the major risk factor would more likely strive to counteract the occurrence of cancer because 
such factors are more easily found within their locus of control than environmental factors. For 
French individuals with intermediate socioeconomic status, their financial problems could induce 
them to view cancer as more intractable and to associate the disease with factors beyond their 
control. Additionally, because many of these people who emphasized the environment as a risk 
factor smoked, it could be a sheer denial that their behaviors are worsening their health. As it 
was the case for the United Kingdom, the French perception of cancer varies with their different 
socioeconomic status, which, in turn, could affect the rate of cancer incidence.  
We could conclude that cultural values were reflected in the perceptions of French 
individuals especially when demographics were taken out of consideration. Some of the 
behavioral factors reflect the French culture, and many French participants in the study 
recognized the influence of these common behaviors on their perceptions of cancer. In general, 
France has a higher smoking rate than many other European countries. For example, in 2017, 
36% of the French population smoked - the second highest rate in all of Europe (second only to 
Greece) (“Smoking Prevalence by Country 2017”). Drinking is another behavioral factor that is 
associated with the French culture, and the study suggests that the participants took these 
behaviors (both drinking and smoking) into consideration when thinking about their perceptions 
of cancer. Some participants also accepted the notion that psychosocial factors posed a risk for 
cancer in France. 49.9% of French participants in the study believed that bitterness due to 
disappointment in professional or personal life could cause cancer (Peretti-Watel et al.) This 
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suggests, once again, that lifestyle choices and cultural values, such as successful and satisfying 
personal and professional life, shape an individual’s awareness of cancer and ultimately affect 
the public’s perception of cancer. Lastly, the study found that youngest respondents believed that 
behavioral risk factors were the most significant threat (Peretti-Watel et al.) Although in reality, 
risk factors vary in impact, the data suggest that the younger generations are more aware that 
their actions could influence the incidence of cancer in France. Hopefully, more education 
among the younger generations about behavioral, psychosocial, and environmental factors 
related to cancer will decrease the national smoking rate as well as cancer incidence in general. 
Education programs would help to inform the population about the significant risk factors for 
cancer and address any misconceptions. Although the French seem to have a pretty good 
understanding of the contributing factors, their cultural norms could interfere with the 
implementation of healthy lifestyle choices to prevent cancer. Since smoking is relatively 
prevalent among the French population, the majority of which recognizes it as a behavior 
predisposing them to cancer, I want to examine their awareness of cancer, and more specifically, 
lung cancer.  
Wynes et al. interviewed 2200 healthy French individuals over the age of 18 on their 
knowledge of lung cancer, including its etiology, diagnosis, and treatments. 93% of the 
individuals sampled acknowledged that active tobacco smoking could cause lung cancer, and 
67% of them recognized that second-hand smoke could play a role in getting cancer. However, 
85% of the people surveyed incorrectly thought that there were noticeable symptoms present for 
developing lung cancer. Additionally, a majority of individuals recognized chemotherapy, 
surgery, and smoking cessation as approaches for treating lung cancer. A lower majority (64%) 
were aware that radiation therapy could be used to treat cancer (Wynes et al.) As with the 
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previous study (Peretti-Watel et al.), the numbers from this study suggest that most French 
individuals are aware of the main risk factors, like smoking, for cancer. However, more public 
education about the dangers of second-hand smoke could help to reduce the incidence of lung 
cancer in this country (which has such a high volume of smokers). Additionally, because so few 
people recognized that early onset of lung cancer had little to no symptoms, education of the 
masses through schools and public campaigns is essential to advocate early screening and 
diagnosis. France could improve the survival rate for lung cancer by stressing tobacco smoke as 
a significant risk factor and by highlighting the benefits of early detection through cancer 
screeninng.  
Given that France is characterized as a country with relatively good awareness about the 
risks and treatments for cancer, I now want to examine their health care system to analyze its 
effect on the public perception of cancer. France has some of the most exceptional health care 
facilities in the world, marked by the outstanding quality of care given to patients at these 
facilities. As mentioned earlier, France is home to the first cancer hospital, which was 
established in 1740. Almost three hundred years later, it only makes sense that France is still at 
the forefront of cancer treatment as it is at the center of Europe, where many developments in 
cancer therapy occurred throughout history. France has the best overall health care system in the 
world which can be attributed to requiring mandatory health care and having more doctors per 
capita than most other European countries (“World Health Organization Assesses the World's 
Health Systems”). France uses 11.5% of its total GDP on health care, which is well above the 
European average (10.1%) and the United Kingdom’s spending average (9.1%) (World Health 
Organization). In terms of cancer, they have ten world-renown cancer institutions offering 
“specialized treatments” for cancer patients (“The Success Rate of Cancer Treatment in 
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France”). Consistent with the previous statement, the country’s major cancer institutes reported a 
rise in cancer survival rate from 72 to 94 percent over the past twenty years as of 2018. France 
adopted more modern-day cancer drugs, unlike the United Kingdom, which may contribute to 
their higher survival rates for cancer than the United Kingdoms. Additionally, most French 
cancer institutes utilize modern equipment, such as radiation oncology machines, for treatment 
(“The Success Rate of Cancer Treatment in France”). Overall, France’s openness of health care 
to all individuals and acceptance of advanced therapies may explain why most French cancer 
patients and non-patients are relatively well aware of the risk factors and treatments of cancer. 
They may feel more inclined to visit clinics and/or hospitals for screening, thereby delaying the 
progression of their diseases. Additionally, the French population acknowledges the health risks 
of certain behaviors perpetuated by cultural values, and thus, their vulnerability to developing the 
disease (mostly among people of higher socioeconomic status). However, public education that 
underscores the benefits of early and regular screening and the toxicity of second-hand smoking 
could still help the French overcome their cultural barriers to restore health and reduce cancer 
cases. Additionally, as a country at the forefront of cancer technology, France could continue to 
develop effective drugs with the participation of its cancer patients and share their knowledge 
with the rest of Europe.  
Of all the countries discussed so far, France seems to have dealt with cancer and cancer 
treatment most adequately in terms of public awareness of cancer and government investment of 
resources. The perceptions of its people are closest to being accurate, and procedures are holistic, 
innovative, and accessible. Presumably, their accessible and advanced health care system helps 
the French know about the latest technologies in cancer therapy and motivates them to seek 
treatments and join clinical trials. This, in turn, can raise public awareness to overcome fears and 
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cultural barriers and direct patients toward cancer prevention and treatment. The last country I 
want to examine is the United States, a melting pot of various cultures and diverse ethnicities. 
The United States, like France, is also at the forefront of cancer technology, although it stepped 
foot in the battle against cancer relatively recently in the late 1800s. It has the fifth highest cancer 
incidence rate in the world - 352.2 people out of 100,000 are diagnosed with cancer at a standard 
age (“Global Cancer Data by Country”). However, the United States has adopted different 
technologies and drugs to fight the high incidence of cancer in its population as best as possible. 
We have seen that educational level is one contributing factor for the public perceptions of 
cancer. The United States has a slightly lower education rate than the United Kingdom (45.67% 
and 45.96%, respectively) (Hess). The question is whether this slight disparity translates into 
similar perceptions of cancer in the two countries, or whether the United States has a better 
awareness of cancer and its risk factors than the United Kingdom and other countries, and, if so, 
the underlying reason.  
Perceptions and Treatment of Cancer: United States 
Different studies have compared the public’s perception of cancer between the United 
States and other countries and between distinct demographic groups in the United States. When 
six different countries (United Kingdom, Japan, Germany, France, Italy, and the United States) 
were compared to each other in terms of cancer perceptions, the United States had the smallest 
proportion of individuals who agreed with the statement that a “cancer diagnosis will ultimately 
result in death,” despite the use of cancer treatments (Ramers-Verhoeven et al.) While 65% of 
the United States participants disagreed with this statement that correlates cancer with inevitable 
death, 73% of the United States respondents underestimated the cost of cancer treatment 
development and approximated the cost of 100 million dollars or less. As it was the case with the 
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United Kingdom, underestimation of the United States’ spending in cancer research and drug 
development could reflect their ignorance of the complexities of cancer treatment, or their lack 
of trust in government funding. However, a majority of those surveyed are aware that cancer is 
treatable although the percentage of individuals who associate cancer with death (35%) is 
relatively high for such a developed country (Ramers-Verhoeven et al.) Another study involving 
United States participants looked more closely at this fear of death associated with cancer in the 
elderly population. In the study, 454 adults aged 50 and older were surveyed about their 
willingness to get screened for colorectal cancer (Bynum et al.) One positive finding from the 
study was that only 15% of the respondents indicated their unwillingness to participate in 
colorectal cancer (CRC) screening. We can extend the result to suggest that most people in the 
older age group in the United States are willing to screen for cancer. Although many admitted 
their fear of screening, which could discover late-stage cancer or cause pain from the procedure, 
a majority of the participants would rather undergo testing to protect their health (Bynum et al.) 
Their awareness of the benefits of cancer screening is consistent with their association of the 
disease with recovery over death, as shown in the previous study (Ramers-Verhoeven et al.)  
The United States, in general, has a good grasp on the reality of cancer; they realize that 
it can potentially be treated to avoid death and that screening, if done early, can be beneficial for 
managing their illness. It is encouraging to see a high rate of willingness to screen for colorectal 
cancer in the older age group, which is more susceptible to the disease than the younger age 
group. In other countries, such as in South Africa and the United Kingdom, we observed that the 
older generation was generally more fearful of cancer and more reluctant of screening than the 
younger generation. The lack of such age-dependent variability in perception and attitude in the 
United States can be ascribed to education. Moreover, despite the ethnic diversity (either African 
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America, Hispanic American, or White) of participants, there was no significant difference in 
their perceptions of colorectal cancer and willingness for screening based on ethnicity (Bynum et 
al.) Hence, we can conclude that the United States’ understanding of cancer is mostly 
independent of variance in age or ethnicity, possibly due to general education across the nation.   
 After looking at perceptions of cancer among individuals from the United States, one 
might assume that if the United States population is reasonably well informed about cancer and 
disposed to receive diagnosis and treatment, then they would actively participate in screening 
and therapy. On the contrary, 39% of the individuals from the colorectal cancer study stated they 
had never even gotten a colonoscopy (an important test used for colorectal cancer diagnosis) 
(Bynum et al.) However, it is clear that fear levels of cancer diagnosis in the United States are 
much lower than in other countries, like India and those in Africa. Besides, the United States 
seems to have a holistic and progressive system for treating cancer patients even though many 
people speculated the United States spends much less on cancer treatment development than it 
actually does. In fact, the United States has spent over one billion dollars on cancer treatment 
development in the past year. I suspect that the United States’ health care system and technology 
can, in part, explain their relatively positive outlook on cancer. On the other hand, a relatively 
low participation rate in screening such as a colonoscopy may reflect inequality in health care 
(which is reflected in the various degrees of health insurance coverage) among people of 
different socioeconomic statuses.  
 One way to measure the efficiency of health care is by calculating the time to cancer 
treatment. As seen with South Africa, the timeline between the patient visit, diagnosis, and 
treatment lasted weeks, if not months, and such delay often caused cancer to progress faster and 
make treatment more difficult. Longer time to treatment initiation (TTI) could be detrimental in 
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other aspects, such as stress and anxiety generated as feelings of helplessness increase in 
patients. In regards to the United States, many health care providers predict that as the health 
care system increases in complexity, the TTI will increase as well. In a study conducted in 2019, 
Khorana et al. tracked TTI over time, between 2004 and 2013, for the United States patients with 
early-stage tumors. They found that the median TTI for various cancers was 27 days in the 
United States (almost seven months shorter than the TTI in South Africa). However, the TTI 
steadily increased over time, from a median of 21 days in 2004 to a median of 29 days in 2013. 
Moreover, it was reported that blacks had a higher TTI than whites, by a difference of 1 
to 6.7 days depending on the type of cancer (Khorana et al.) This was interesting because the 
previous study (Bynum et al.) suggested that minorities in the United States do not significantly 
differ in their perceptions of cancer from other ethnicities; but it seems that the treatments 
utilized could be disproportionate for certain ethnic groups based on the study. Although many 
different explanations could be posed for why this is the case, no satisfying answer explains this 
discrepancy. One potential reason could be socioeconomic status, which may affect an 
individual’s affordability of the treatments and in turn their TTI. Additionally, TTI influenced 
the survival rates for cancer. “Prolonged TTI” (defined as greater than six weeks) decreased 
survival rate significantly across all cancers except prostate cancer (Khorana et al.) However, 
because the study found that the median time was around 27 days, it suggests that the United 
States’ health care system is currently doing an excellent job of delivering cancer treatments 
efficiently relative to underdeveloped countries. This could potentially explain the lower fears 
associated with a cancer diagnosis in the United States. Because the United States is relatively 
efficient in treating cancer with high-quality treatments such as surgery, chemotherapy, radiation 
therapy, and multimodal therapies, cancer patients and non-patients are likely to have less to fear 
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even if their cancer is not caught in a primitive stage. However, if TTI indeed lengthens over 
time as predicted by health care professionals, then the survival rate is expected to fall, and the 
United States perception of cancer may not be the same in the future.  
Conclusions 
The history of cancer in the human race is one that is long and extensive. Even thousands 
of years ago, individuals were not immune to the fatal grasp of the illness, and it still continues to 
adversely affect individuals across the world every day. However, it is important to recognize 
that although all individuals have a chance of being affected with the illness (some more than 
others due to their lifestyle choices and genes), not all individuals around the world have similar 
accessibility to and availability of resources. This may stem from the fact that perceptions of 
cancer vary between and among regions. Some regions are populated by individuals who are 
relatively unaware of cancer and its risk factors, which we observed in India and South Africa 
specifically, and others are relatively well educated in cancer risk factors and treatment (France 
and the United States). These differences in perception, as well as the history of cancer and its 
treatment in those regions, in turn, influence the treatments that are offered and utilized by 
cancer patients in those regions.  After looking at six countries all around the world (Korea, 
India, South Africa, United Kingdom, France, and the United States), there are specific measures 
that, if implemented, could potentially decrease the rate of cancer incidence and increase the rate 
of cancer survival in every country by improving perceptions of cancer. One of these measures is 
education, which can be enriched in both underdeveloped and developed countries. The 
perception of cancer varies within every country by demographic factors and between nations by 
economic and education levels. However, it is also crucial to remember that not everyone in any 
given country is aware of the risk factors, causes, and treatments of cancer, and their perception 
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can influence their own course of disease. Opinions of cancer seem to vary with an individual’s 
socioeconomic status, religion, education level, or ethnicity and it is because of this that I stress 
the significance of education. Education programs implemented by the government and 
advocacy programs initiated by the public can help to fix misconceptions of cancer so that fear 
and misinformation are not limiting an individual’s ability to seek out medical help. Much of the 
population of India and Africa (especially those living in rural areas), and even some individuals 
of Korea are dictated by fear of their diagnosis and treatments. Especially in places like India and 
Africa, where advanced therapies like chemotherapy and radiation therapy are infrequent and 
unaffordable, education is vital in catching cancer early so that it does not progress to a point 
where the limited treatments they receive no longer prove to be beneficial.  
Korea was a good example that demonstrated the potential of clinical trials and research 
in cancer therapy. Many Korean patients were unwilling to participate in clinical trials despite 
their awareness of the benefits, and this only proved to be detrimental for cancer research. 
Clinical trials are vital for testing out new cancer treatments for improved therapy, and the 
participation of cancer patients is crucial to test the efficacy of drugs. Without their participation, 
cancer treatment development will be at a standstill, and cancer therapy cannot progress any 
further. Especially in countries like France and the United States, which are willing to utilize 
new cancer drugs and therapies, clinical trials help to speed up the process of drug approval and 
marketing to the public. This is another reason why education of the population is so important. 
Many individuals fear the consequences of participation in clinical trials, but do not understand 
the essence and benefits of participation. Education programs across all countries and all regions 
are essential for perpetuating accurate awareness of cancer. It will allow patients to manage their 
fear of cancer, to mobilize them to get tested and screened earlier, and to diagnose and treat their 
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potential disease earlier and more efficiently. This is important especially in countries where the 
cancer treatments available are not the most advanced, such as South Africa, Nigeria, and India, 
and so they need to rely on the most basic forms of treatment, such as surgery, which will work 
best for cancer in the initial stage. Education of such large and diverse populations around the 
world will take time, but I believe that with time, education will eventually mitigate people’s fear 
of cancer and will encourage them to seek out help and treatment if needed. Every individual 
deserves the right to take care of their health, and accurate and health perceptions of cancer, as 
well as appropriate and affordable treatments available in different regions, could eventually 
diminish death rates and alleviate unnecessary suffering among cancer patients as they are 
slowly but surely mobilized to get the treatment they need and deserve. 
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